Victoria Reiser, NP
Adult Health · Aurora, CONPI 1285263152
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by AstraZeneca at 45.3% of the total. 2024 is the largest year on record at $997, more than ten times the $76 reported in 2021.
Across 14 payments — averaging $137.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$870
- Gilead$234
- Incyte Corporation$177
- EMD Serono, Inc.$121
- Seagen Inc.$113
- Johnson & Johnson$100
- plus $306 from 5 others
What the payments were for
- Consulting fees$87045%
- Food & beverage$74639%
- Education$30516%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 1 | $870 |
| Gilead | 3 | $234 |
| Incyte Corporation | 2 | $177 |
| EMD Serono, Inc. | 1 | $121 |
| Seagen Inc. | 1 | $113 |
| Johnson & Johnson | 1 | $100 |
| Myovant Sciences Inc. | 1 | $81 |
| Heron Therapeutics, Inc. | 1 | $76 |
| Lilly USA, LLC | 1 | $72 |
| Novartis | 1 | $55 |
| Mirati Therapeutics, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,921 in reported general payments places this provider in the 80th percentile of 430 adult health providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $8,307 |
| Anastrozole | 52 | $739 |
| Oxycodone Hcl | 12 | $648 |
| Letrozole | 15 | $441 |
| Tamoxifen Citrate | 18 | $389 |
| Hydroxyurea | 12 | $381 |
Paid to pharmacies, not to this prescriber.
Other adult health in Aurora
- Stefanie EymarAurora$36K
- Alexandra GravesAurora$18K
- Keri HalsemaAurora$17K
- Grace WorlandAurora$11K
- Glen PetersonAurora$8K
- Amber KohlerAurora$6K
- Kimberly NdahayoAurora$5K
- Susan EstesAurora$5K
- Aparna GuptaAurora$5K
- Ann PereiraAurora$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.